HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Miao Selected Research

Li Miao Research Topics

Disease

8Neoplasms (Cancer)
04/2021 - 06/2002
5Hypothyroidism
05/2021 - 01/2015
4Inflammation (Inflammations)
12/2023 - 01/2019
4Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2023 - 01/2021
4Neoplasm Metastasis (Metastasis)
08/2023 - 02/2004
4Type 2 Diabetes Mellitus (MODY)
01/2017 - 12/2014
4Insulin Resistance
06/2016 - 01/2015
3Stomach Neoplasms (Stomach Cancer)
04/2021 - 02/2011
3Prostatic Neoplasms (Prostate Cancer)
05/2016 - 06/2002
2Hyperglycemia
04/2020 - 12/2014
2Hyperalgesia
01/2019 - 06/2008
2Body Weight (Weight, Body)
01/2017 - 01/2015
2Glucose Intolerance
07/2015 - 12/2014
2Obesity
01/2015 - 12/2014
1Wounds and Injuries (Trauma)
02/2024
1Respiratory Hypersensitivity
12/2023
1Arthritis (Polyarthritis)
12/2023
1Asthma (Bronchial Asthma)
12/2023
1Hypochromic Anemia (Chlorosis)
05/2023
1Infections
01/2023
1Spinal Cord Injuries (Spinal Cord Injury)
01/2023
1Necrosis
02/2022
1COVID-19
02/2021
1Necrotizing Enterocolitis
01/2021
1Rheumatoid Arthritis
11/2020
1Diabetic Cardiomyopathies
04/2020
1Hypoxia (Hypoxemia)
11/2019
1Choroidal Neovascularization
01/2019
1Uveitis
01/2019
1Periodontitis
12/2017
1Overweight
01/2017
1Starvation
01/2017
1Fibrosis (Cirrhosis)
09/2016
1Myocardial Ischemia (Ischemic Heart Diseases)
09/2016
1Pain (Aches)
09/2016

Drug/Important Bio-Agent (IBA)

4HomocysteineIBA
05/2021 - 01/2015
3Thyroxine (Levothyroxine)FDA LinkGeneric
05/2021 - 06/2016
3Therapeutic UsesIBA
01/2017 - 02/2010
2A-factor (Streptomyces)IBA
08/2023 - 01/2021
2Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2004
2HMGB1 Protein (HMG1)IBA
02/2022 - 01/2021
2CytokinesIBA
01/2019 - 12/2017
2Apolipoprotein A-I (Apolipoprotein A1)IBA
07/2016 - 07/2015
2Glucose (Dextrose)FDA LinkGeneric
01/2015 - 12/2014
2Blood Glucose (Blood Sugar)IBA
01/2015 - 12/2014
2Messenger RNA (mRNA)IBA
12/2014 - 10/2014
2SurvivinIBA
01/2012 - 02/2011
2ProdrugsIBA
01/2012 - 02/2004
2Prostate-Specific Antigen (Semenogelase)IBA
02/2004 - 06/2002
2AndrogensIBA
02/2004 - 06/2002
1HydrogelsIBA
02/2024
1StigmasterolIBA
12/2023
1AntioxidantsIBA
12/2023
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
12/2023
1Malondialdehyde (Propanedial)IBA
05/2023
1TitaniumIBA
01/2023
1Interleukin-6 (Interleukin 6)IBA
02/2022
1InterleukinsIBA
02/2022
1CreatinineIBA
05/2021
1Interleukin-10 (Interleukin 10)IBA
04/2021
1Long Noncoding RNAIBA
01/2021
1squamous cell carcinoma-related antigenIBA
01/2021
1Caspase 8 (Caspase-8)IBA
01/2021
1CateninsIBA
11/2020
1BerberineIBA
11/2020
1p38 Mitogen-Activated Protein KinasesIBA
11/2020
1LiraglutideFDA Link
04/2020
1Glucagon-Like Peptide-1 ReceptorIBA
04/2020
1Phosphopyruvate Hydratase (Enolase)IBA
03/2020
1LipopolysaccharidesIBA
11/2019
1Triiodothyronine (Liothyronine)FDA LinkGeneric
04/2019
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
04/2019
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2019
1Fluorescein (Funduscein)FDA LinkGeneric
01/2019
1pyrimidin-2-one beta-ribofuranosideIBA
01/2019
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
01/2019
1Guanylate Cyclase (Guanylyl Cyclase)IBA
01/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019
1Dizocilpine Maleate (Dizocilpine)IBA
01/2019
1JNK Mitogen-Activated Protein KinasesIBA
01/2019
1Retinaldehyde (Retinal)IBA
01/2019
1ifenprodilIBA
01/2019
1Interleukin-12 (IL 12)IBA
12/2017
1Bile Acids and Salts (Bile Acids)IBA
01/2017
1Metformin (Glucophage)FDA LinkGeneric
01/2017
1LipidsIBA
01/2017
1Exenatide (Byetta)FDA Link
01/2017
1CholesterolIBA
06/2016

Therapy/Procedure

5Therapeutics
01/2017 - 06/2007
4Radiotherapy
08/2023 - 01/2021
2Drug Therapy (Chemotherapy)
08/2023 - 01/2021
2Chemoradiotherapy
01/2022 - 01/2021
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
05/2021
1Dental Care
02/2021
1Consolidation Chemotherapy
01/2021
1Lasers (Laser)
01/2019
1Glycemic Control
01/2017
1Analgesia
09/2016
1Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2016